Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
What is dabrafenib mesylate msn patent issue?Allergan's patent for latisse expired?Dabrafenib btd date 2023?Is allopurinol expensive?Drugpatentwatch skyrizi biologic patent analysis?
See the DrugPatentWatch profile for atorvastatin
“Lipitor” is the brand name for atorvastatin. So there is no separate potency value for Lipitor versus atorvastatin; Lipitor’s HMG‑CoA reductase inhibition potency comes from atorvastatin itself. [1]
In general, the active ingredient is the same (atorvastatin), so the potency with respect to HMG‑CoA reductase inhibition should be the same in the absence of formulation-related bioavailability differences. Any change you might see in real-world effect would come from how the dose is absorbed and reaches the bloodstream, not from a different intrinsic HMG‑CoA reductase inhibition strength. [1]
If you’re comparing doses (for example, 10 mg vs 20 mg vs 80 mg), then higher doses generally correspond to stronger lipid-lowering and thus stronger functional HMG‑CoA reductase inhibition, because you have more of the same active ingredient. The comparison is dose-dependent, not brand-dependent. [1] Sources: [1] FDA Prescribing Information for Lipitor (atorvastatin calcium): https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm
Other Questions About Atorvastatin :